| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse Events with d-penicillamine Therapy in Hepatic Wilson’s Disease: A Single-Center Retrospective Audit
|
Kumar, Sanjay
|
|
|
42 |
2 |
p. 177-184
|
artikel
|
| 2 |
Comparative Bioavailability Study of a New Vitamin D3 Orodispersible Film Versus a Marketed Oral Solution in Healthy Volunteers
|
Radicioni, Milko
|
|
|
42 |
2 |
p. 151-161
|
artikel
|
| 3 |
Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept
|
Varadhan, Lakshminarayanan
|
|
|
42 |
2 |
p. 113-125
|
artikel
|
| 4 |
Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients
|
Fuchs, Vered
|
|
|
42 |
2 |
p. 185-192
|
artikel
|
| 5 |
Opicapone for the Treatment of Parkinson’s Disease "Off" Episodes: Pharmacology and Clinical Considerations
|
Berger, Amnon A.
|
|
|
42 |
2 |
p. 127-135
|
artikel
|
| 6 |
Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke
|
Sakai, Nobuyuki
|
|
|
42 |
2 |
p. 137-149
|
artikel
|
| 7 |
Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17
|
Viapiana, Ombretta
|
|
|
42 |
2 |
p. 103-112
|
artikel
|
| 8 |
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial
|
Braal, C. Louwrens
|
|
|
42 |
2 |
p. 163-175
|
artikel
|
Tijdschrift beschrijving